Medical technologies

Medical technologies

April 30, 2018

Actelion Submits Supplemental New Drug Application to US FDA Seeking Approval of OPSUMIT® (macitentan) for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Learn more

Medical technologies

April 26, 2018

New PROTI 360° Family of Implants from DePuy Synthes Is Designed to Enhance Spinal Fusion Surgery Outcomes

Learn more

Medical technologies

April 11, 2018

Johnson & Johnson Vision Announces Revolutionary Contact Lens Innovation with ACUVUE OASYS® with Transitions® Light Intelligent Technology™

Learn more

Medical technologies

April 6, 2018

Johnson & Johnson Institute Adds Innovative Analytics-Based Learning Platform to Help Surgeons Improve Technical Skills and Clinical Outcomes Across a Range of Specialties

Use of digital technology and analytics will reinvent professional education

Learn more

Medical technologies

February 27, 2018

ACCLARENT RECEIVES FDA CLEARANCE FOR EXPANDED INDICATION OF ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM

Learn more

Medical technologies

February 20, 2018

Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics

Learn more

Medical technologies

February 14, 2018

ERLEADA™ (apalutamide), a Next-Generation Androgen Receptor Inhibitor, Granted U.S. FDA Approval for the Treatment of Patients with Non-Metastatic Castration-Resistant Prostate Cancer

Learn more

Medical technologies

February 8, 2018

ERLEADA™ (apalutamide), a Next-Generation Androgen Receptor Inhibitor, Lowered Risk of Metastasis or Death in Patients with Non-Metastatic Castration-Resistant Prostate Cancer

Learn more

Medical technologies

February 8, 2018

ZYTIGA® (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer

Learn more